Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-28

Clinical Trial Update: Pamidronate Administration in Breast Cancer Patients With Bone Metastases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on pamidronate administration in breast cancer patients with bone metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pamidronate (pamidronate disodium)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 4 | Status: COMPLETED